Last checked at 24 Mar 2020 11:31
24 March 2020
Marlowe plc
("Marlowe" or the "Company")
Issue of Equity
The Company announces that, following an exercise under a long-term incentive scheme, application has been made for 14,754 ordinary shares of 50 pence each in the Company ("New Ordinary Shares") to be admitted to trading on AIM. The New Ordinary Shares will rank pari-passu with existing ordinary shares, and it is expected that admission will occur at 8.00 a.m. on 30 March 2020.
Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 45,883,835 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 45,883,835.
The above figure of 45,883,835 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information: | www.marloweplc.com |
Marlowe plc | 0203 813 8498 |
Alex Dacre, Chief Executive | IR@marloweplc.com |
Mark Adams, Group Finance Director | |
Cenkos Securities (Nominated Adviser & Joint Broker) | 0207 397 8900 |
Nicholas Wells Ben Jeynes Harry Hargreaves | |
Joh. Berenberg, Gossler & Co. KG, London Branch (Joint Broker) Ben Wright Mark Whitmore
FTI Consulting | 0203 207 7800
0203 727 1340 |
Nick Hasell | |
Alex Le May |